301 related articles for article (PubMed ID: 25636411)
1. Genome-Wide Analysis of Wilms' Tumor 1-Controlled Gene Expression in Podocytes Reveals Key Regulatory Mechanisms.
Kann M; Ettou S; Jung YL; Lenz MO; Taglienti ME; Park PJ; Schermer B; Benzing T; Kreidberg JA
J Am Soc Nephrol; 2015 Sep; 26(9):2097-104. PubMed ID: 25636411
[TBL] [Abstract][Full Text] [Related]
2. Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.
Dong L; Pietsch S; Tan Z; Perner B; Sierig R; Kruspe D; Groth M; Witzgall R; Gröne HJ; Platzer M; Englert C
J Am Soc Nephrol; 2015 Sep; 26(9):2118-28. PubMed ID: 25556170
[TBL] [Abstract][Full Text] [Related]
3. Activation of podocyte Notch mediates early Wt1 glomerulopathy.
Asfahani RI; Tahoun MM; Miller-Hodges EV; Bellerby J; Virasami AK; Sampson RD; Moulding D; Sebire NJ; Hohenstein P; Scambler PJ; Waters AM
Kidney Int; 2018 Apr; 93(4):903-920. PubMed ID: 29398135
[TBL] [Abstract][Full Text] [Related]
4. Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in Xenopus.
White JT; Zhang B; Cerqueira DM; Tran U; Wessely O
Development; 2010 Jun; 137(11):1863-73. PubMed ID: 20431116
[TBL] [Abstract][Full Text] [Related]
5. Super-Enhancer-Associated Transcription Factors Maintain Transcriptional Regulation in Mature Podocytes.
Yang J; Zhang D; Motojima M; Kume T; Hou Q; Pan Y; Duan A; Zhang M; Jiang S; Hou J; Shi J; Qin Z; Liu Z
J Am Soc Nephrol; 2021 Jun; 32(6):1323-1337. PubMed ID: 33771836
[TBL] [Abstract][Full Text] [Related]
6. Wt1a, Foxc1a, and the Notch mediator Rbpj physically interact and regulate the formation of podocytes in zebrafish.
O'Brien LL; Grimaldi M; Kostun Z; Wingert RA; Selleck R; Davidson AJ
Dev Biol; 2011 Oct; 358(2):318-30. PubMed ID: 21871448
[TBL] [Abstract][Full Text] [Related]
7. Alternatively spliced isoforms of WT1 control podocyte-specific gene expression.
Lefebvre J; Clarkson M; Massa F; Bradford ST; Charlet A; Buske F; Lacas-Gervais S; Schulz H; Gimpel C; Hata Y; Schaefer F; Schedl A
Kidney Int; 2015 Aug; 88(2):321-31. PubMed ID: 25993318
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury.
Chen J; Wang X; He Q; Yang HC; Fogo AB; Harris RC
Kidney Int; 2024 Jun; 105(6):1200-1211. PubMed ID: 38423183
[TBL] [Abstract][Full Text] [Related]
9. PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression.
Wang D; Li Y; Wu C; Liu Y
PLoS One; 2011 Feb; 6(2):e17048. PubMed ID: 21390327
[TBL] [Abstract][Full Text] [Related]
10. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
12. The miR-143/145 cluster induced by TGF-β1 suppresses Wilms' tumor 1 expression in cultured human podocytes.
Tabei A; Sakairi T; Hamatani H; Ohishi Y; Watanabe M; Nakasatomi M; Ikeuchi H; Kaneko Y; Kopp JB; Hiromura K
Am J Physiol Renal Physiol; 2023 Jul; 325(1):F121-F133. PubMed ID: 37167274
[TBL] [Abstract][Full Text] [Related]
13. Lmx1b and FoxC combinatorially regulate podocin expression in podocytes.
He B; Ebarasi L; Zhao Z; Guo J; Ojala JR; Hultenby K; De Val S; Betsholtz C; Tryggvason K
J Am Soc Nephrol; 2014 Dec; 25(12):2764-77. PubMed ID: 24854274
[TBL] [Abstract][Full Text] [Related]
14. Studies on the Role of the Transcription Factor Tcf21 in the Transdifferentiation of Parietal Epithelial Cells into Podocyte-Like Cells.
Kliewe F; Kuss AW; Siegerist F; Schröder S; Schordan S; Artelt N; Kindt F; Amann K; Lindenmeyer MT; Endlich K; Endlich N
Cell Physiol Biochem; 2021 Jun; 55(S4):48-67. PubMed ID: 34148307
[TBL] [Abstract][Full Text] [Related]
15. Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.
Zhou L; Li Y; He W; Zhou D; Tan RJ; Nie J; Hou FF; Liu Y
J Am Soc Nephrol; 2015 Mar; 26(3):677-91. PubMed ID: 25071087
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic transcriptional reprogramming by WT1 mediates a repair response during podocyte injury.
Ettou S; Jung YL; Miyoshi T; Jain D; Hiratsuka K; Schumacher V; Taglienti ME; Morizane R; Park PJ; Kreidberg JA
Sci Adv; 2020 Jul; 6(30):eabb5460. PubMed ID: 32754639
[TBL] [Abstract][Full Text] [Related]
17. Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation.
Green LM; Wagner KJ; Campbell HA; Addison K; Roberts SG
Nucleic Acids Res; 2009 Feb; 37(2):431-40. PubMed ID: 19050011
[TBL] [Abstract][Full Text] [Related]
18. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
19. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.
Kim MS; Yoon SK; Bollig F; Kitagaki J; Hur W; Whye NJ; Wu YP; Rivera MN; Park JY; Kim HS; Malik K; Bell DW; Englert C; Perantoni AO; Lee SB
J Biol Chem; 2010 May; 285(19):14585-93. PubMed ID: 20220130
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel Wilms' tumor suppressor gene target genes implicated in kidney development.
Kim HS; Kim MS; Hancock AL; Harper JC; Park JY; Poy G; Perantoni AO; Cam M; Malik K; Lee SB
J Biol Chem; 2007 Jun; 282(22):16278-87. PubMed ID: 17430890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
